Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $34.37M in the quarter ending March 31, 2026, with 55.50% growth. This brings the company's revenue in the last twelve months to $51.48M, down -12.58% year-over-year. In the year 2025, Kymera Therapeutics had annual revenue of $39.21M, down -16.70%.

• Revenue (ttm): $51.48M
• Revenue Growth: -12.58%
• P/S Ratio: 159.59
• Revenue / Employee: $203,462
• Employees: 253
• Market Cap: 8.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	39.21M	-7.86M	-16.70%
Dec 31, 2024	47.07M	-31.52M	-40.11%
Dec 31, 2023	78.59M	31.77M	67.84%
Dec 31, 2022	46.83M	-26.01M	-35.71%
Dec 31, 2021	72.83M	38.80M	114.00%
Dec 31, 2020	34.03M	31.10M	1,059.99%
Dec 31, 2019	2.93M	-	-
Dec 31, 2018	2.93M	-	-

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 22, 2026

Data Sources Report a data error